AJMC

#SGLT2 inhibitors protect the heart and kidneys, not just glucose.

So why are 𝐞𝐥𝐢𝐠𝐢𝐛𝐥𝐞 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐬𝐭𝐢𝐥𝐥 𝐦𝐢𝐬𝐬𝐢𝐧𝐠 𝐨𝐮𝐭?
Watch this video on fragmented care, specialty silos, and how payers can close the gap: hubs.li/Q04CcpfG0
#CKD #ManagedCare

Experts told #AJMC at the GOLD International COPD Conference that earlier diagnosis and intervention could most improve #COPD outcomes within 5 years.

Watch here: hubs.li/Q04DM3Tz0

#Diabetes and functional dependence, not severe #obesity alone, were linked to higher graft failure 3 years after liver transplant for #MASH, according to Sri Harsha Boppana, MD, at AASLD’s The Liver Meeting 2026 (#TLM26).

Watch here: hubs.li/Q04DM2YW0

#HepatitisB functional cure with #bepirovirsen held in 90% to 92% of responders 48 weeks after stopping all therapy, per data at The Liver Meeting 2026 (#TLM26).

Learn more here: hubs.li/Q04DM29z0

Building a cellular therapy program is one challenge. Delivering treatment across the full patient journey is another. 

Register today: hubs.li/Q04CNt9Y0  

Looking forward to hearing insights from Ahmed Galal, Tracy Schoenhoft, Jehad Al Masri, and Christine Pfaff!